Testing MOUD Scale-Up in Correctional Institutions
This study is testing ways to increase the use of Medications for Opioid Use Disorder (MOUD) in prisons. MOUD are treatments that help people with opioid addiction. Researchers will try out two strategies: a policy academy and a learning collaborative. The goal is to see if these methods can help more incarcerated individuals get MOUD, which is important because it can reduce overdose deaths after release. The study aims to measure how much these strategies help prisons offer MOUD over two years. This study is for correctional institutions that want to offer or increase MOUD, have funds for the medication, and have support from their leadership. The current recruitment status is unclear.
- Study design
- This interventional study will involve 120 correctional institutions across 12 U.S. states. It will evaluate two different strategies to scale up MOUD programs.
- What's involved
- The learning collaborative involves learning sessions at the beginning and monthly coaching sessions for 12 months. This is to help staff implement the study protocol and understand MOUD.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome, reach of systems-change for scaling MOUD, will be measured at 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Testing MOUD Scale-Up
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Todd Molfenter, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison
- Rosemarie Martin, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Reach of systems-change for scaling medications for MOUD2 years
Using the RE-AIM framework, reach is measured by number of MOUD (buprenorphine, methadone, injectable naltrexone) standardized medication units purchased by prisons in a state